LONDON: The Chinese pharmaceutical company Cipla has agreed to pay US$1bn (£1.2bn) to resolve allegations it sells counterfeit Viagra and other medicines to the US Food and Drug Administration (FDA) that could have a positive effect on its medicines list, according to a press release.
LONDON, which is based in London and is known as the "City of Death" in English, said the company had signed an agreement to pay US$1.2bn to resolve allegations that it marketed and sold counterfeit and unapproved medicines to the FDA and other companies.
A Pfizer spokesperson said: "The company is committed to resolving the matter and will complete the entire process with full confidence in our relationships and our compliance with applicable laws and regulations."
A Cipla spokesman said: "Cipla has been a major player in the global pharmaceutical market for a number of years and is committed to the continued effectiveness and safety of our medicines.
"Cipla is committed to providing consumers with safe and effective medicines, both prescription and over-the-counter, and to holding the FDA responsible for any misbranded products that could be marketed or sold to consumers."
Cipla said: "Cipla has a strong global presence and is committed to the safety, efficacy and effectiveness of our medicines, including any products that may be potentially dangerous or that could be potentially harmful to consumers."
The company said it would continue to provide a list of approved medicines and any products that it knew were safe to use.
The FDA's investigation revealed that Cipla purchased more than 1,300 counterfeit drugs and over 3,500 unapproved and counterfeit medicines from China, India and other countries.
The FDA said it had received more than 2,100 complaints from consumers and a list of 3,800 drug products in more than 50 countries.
In a letter to the F. D. A. it said the agency had "engaged in a multi-year investigation to determine whether Cipla was involved in these illegal activities."
The agency added that the investigation had found "serious and pervasive" drug safety issues and that they had "conducted a thorough investigation of the matter."
A Pfizer spokesperson said: "Pfizer is committed to resolving this matter and will complete the entire process with full confidence in our relationships and our compliance with applicable laws and regulations."
The company has not commented on the F. investigation and said the company did not have any immediate comment.
In May, Cipla's global sales were estimated at $2.3 billion, or 15 per cent less than its US$1.4 billion peak sales.Cipla has been a major player in the global pharmaceutical market for a number of years and is committed to the safety, efficacy and effectiveness of our medicines, including any products that may be potentially dangerous or that could be potentially harmful. (Image: Getty Images)In October, the company announced it would begin selling the anti-impotency drug sildenafil in the US.US FDA warning against buying unapproved medicines is a top US company's warning to customers, the FDA said, noting that some medicines can be harmful to patients.The agency added that it would review all the available information about such products, including their safety, effectiveness and side effects, and would "review all of the available information" to assess whether they were appropriate to buy.
A Cipla spokesperson said: "We are committed to working closely with the FDA to ensure that all medicines sold to our customers are reviewed to ensure safe and effective products."The company, which is based in Tempe, Arizona, has been a major player in the global pharmaceutical market for a number of years and is committed to the safety, efficacy and effectiveness of our medicines, including any products that may be potentially dangerous or that could be potentially harmful.
Cipla said that it had "remarkably large" revenue share in the US from selling unapproved and counterfeit medicines to consumers and to health care professionals.
In October, the company said that it was reviewing all the available information about such products, including their safety, effectiveness and side effects, and would review all of the available information to assess whether they were appropriate to buy.
Cipla said it was working closely with the FDA in monitoring the safety of medicines sold in the US and in other countries.Cipla's US sales have been estimated to be $1.3bn, or 15 per cent less than its sales in the US last year.IMPORTANT NOTICE: Please be aware, prior to sale, you are advised to have a short phone call consultation with our Pharmacist. Automatic purchase consents the Pharmacist to give you a quick call.
Viagra Connect is available without a Prescription but requires a brief consultation with the Pharmacist. It is available in a 4 pack or an 8 pack. Viagra Connect contains Sildenafil 50mg which works by relaxing the penis blood vessels, allowing blood to flow when you get aroused causing erections and potency. Viagra Connect will only help men become erect if you are aroused. Only for adult use, men 18 years plus.
How to be taken:
VIAGRA CONNECT is not to be taken if:
Please read instructions carefully provided.
Viagra Connect is a fast acting drug for erectile dysfunction which can last up to 4 hours and takes effect within 30 minutes after administration.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile disfunction and is highly effective in treating it, the most common sexual disorder affecting men over the age of 40 years. Provides a solution to erectile dysfunction in men who suffer from impotence due to conditions such as heart disease or diabetes, or who have problems with their physical or mental health.
Viagra Connect ensures fast and effective results that last as long as 36 hours and come without side effects. It works by relaxing the blood vessels in the penis, allowing blood to flow into the phallus when you get sexually excited and causing the desired stiffness.
IMPORTANT NOTICE: You are advised to have a short phone call consultation with our Pharmacist. The Pharmacist is will then of the option to offer a quick consultation with the Dodhi Pharmacy, a trained pharmacy that is certified to provide safe and discreet services to customers.For those who have a short phone call consultation with our Pharmacist, you can give the Pharmacist a call now through the website or by calling our branch of delivery at the above address. You will be able to complete a short online consultation with our Pharmacist at the close of a business day. They will of the option to give you a quick call with a phone with an offer for a prescription.
Share your comments:NEW DELHI: Pfizer Inc. on Tuesday (Aug 4) will launch its anti-impotence drug Viagra 50mg, with US generic competitor Teva Pharmaceutical Industries Ltd. on June 5, when the US Food and Drug Administration approves its first generic equivalent for impotence treatment.
The company, which sells generic versions of its two-ingredient drug, Viagra, in the US, has launched its own version of the drug in India, the US news agency.
Pfizer is one of the world's largest pharmaceutical companies with sales of US $1.58 billion in 2015, according to IMS Health. In India, Pfizer's sales have been around US$1.6 billion, with Viagra accounting for the largest segment, according to IMS.
The US drug's launch came several months after the FDA approved Viagra for impotence treatment, which it has already been approved for in India. Viagra is a brand-name drug, the US Food and Drug Administration (FDA) said.
In the US, Pfizer's sales in 2016 were around US$0.9 billion, according to IMS. Pfizer's sales have also been around US$2.1 billion, according to IMS.
Viagra is a blue-milling drug and is sold under the brand name Cialis. Viagra's patent was set to expire in late 2013, but Cialis is still under development.
The US patent on Viagra expires in 2019, but Pfizer is working on a similar patent in India. It will be sold to the Indian pharmaceutical companies in the US by the end of this year.
Pfizer's Viagra patent for impotence treatment expired in 2013. Teva Pharmaceutical Industries Ltd.Viagra's patent for impotence treatment expired in the US in 2014. The US patent for Viagra is set to expire in the next three years, but other Indian companies are still developing the drug. Pfizer is the world's largest pharmaceutical company with sales of US$1.6 billion in 2015.
Viagra is used to treat erectile dysfunction, a condition involving an inability to achieve or maintain a hard, erect penis suitable for sexual activity. It belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. Viagra works by relaxing the blood vessels in your penis, allowing blood to flow into the penis when you are sexually excited.
It is used to treat impotence, a condition in which a man cannot achieve or maintain a hard erection suitable for sexual activity. It is available in the form of tablets, creams, or gels, and is taken by mouth. It is not recommended to take more than one pill in a day, and men may experience dizziness, lightheadedness, fainting, or an irregular heartbeat.
Viagra has been available in the US since 1998. Viagra is a brand-name drug that is manufactured by Pfizer. Pfizer has patents for more than 50 years, and it is the only pharmaceutical company in the world to manufacture Viagra. Pfizer has patents for 60 years.
The Indian market for Viagra is estimated at US$1.2 billion. Viagra is sold by more than 150 manufacturers and 60 countries. Viagra is used to treat impotence, a condition in which a man cannot achieve or maintain a hard erection suitable for sexual activity.
Viagra is not available on the US market. Pfizer has an Indian patent for Viagra.
Viagra has a long-standing patent protecting it. Pfizer was granted a patent for Viagra in India in 2002. It was later granted a generic version for impotence treatment, called Cialis.
Pfizer's patent for impotence treatment expired in 2019, but other Indian companies are still developing the drug.
The US patent for Viagra expires in 2019, but other Indian companies are still developing the drug.
Pfizer's Viagra patent for impotence treatment expired in the US in 2014.Viagra is used to treat erectile dysfunction, a condition in which a man cannot achieve or maintain a hard erection suitable for sexual activity.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Inactive product (Pickrae) [ edit 2015-05-01 ]Sildenafil 100mg
Treatment of Erectile dysfunction (impotence).
Treat erectile dysfunction.
Treatment of erectile dysfunction. Can take 4-6 hours before sexual activity.
Safety for the user. May not be used by those with certain health conditions.
Stade de France Pharmacy